Search results for " tolerance"

showing 10 items of 760 documents

Sex differences on peak oxygen uptake in heart failure

2019

Women represent nearly half of the adult heart failure (HF) population and they remain underrepresented in HF studies. We aimed to evaluate the evidence about peak oxygen uptake (peak VO2) for clinical stratification in women with HF. This narrative review summarizes (i) the evidence endorsing the value of cardiopulmonary exercise testing for clinical stratification and phenotyping HF population; (ii) the determinants of a person’s functional aerobic capacity to understand predicted values for patients with chronic HF; and (iii) sex differences on peak VO2 data in different forms of HF. Lastly, based on existing data in patients with HF, we provide a perspective on how to improve existing g…

Adultlcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyPopulationReviewsHeart failureReview030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesOxygen Consumption0302 clinical medicineInternal medicineSex differencesmedicineHumansIn patient030212 general & internal medicineeducationPeak oxygen uptakeAerobic capacityAgedAged 80 and overHeart FailureSex Characteristicseducation.field_of_studyExercise ToleranceEjection fractionbusiness.industryVO2 maxStroke VolumeMiddle AgedPrognosisClinical stratificationmedicine.diseaseOxygenPhenotypelcsh:RC666-701Heart failureExercise TestCardiologyFemaleGender gapCardiology and Cardiovascular MedicineRisk assessmentbusinessESC Heart Failure
researchProduct

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabol…

2011

BACKGROUND: Women with polycystic ovary syndrome (PCOS) frequently exhibit central obesity, glucose intolerance, atherogenic dys- lipidemia and hypertension, which are characteristic features of a condition of cardiometabolic risk. Our objective was to investigate the relationship between visceral adiposity index (VAI) and phenotypic characteristics in women with PCOS. METHODS: We conducted a cross-sectional case-control study in our Endocrinology Outpatients Clinic. A total of 220 women with PCOS (Rotterdam definition) and I44 age- and BMI-matched healthy women were studied. We evaluated hyperandrogenemia and clinical hyperandrogenism, ovarian morphology, hypothalamic-hypophyseal axis and …

Adultmedicine.medical_specialtyAdolescentPopulationIntra-Abdominal FatSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsInternal medicinemedicinePCOSHumanseducationAdiposityRetrospective StudiesMetabolic Syndromeeducation.field_of_studyGlucose tolerance testmedicine.diagnostic_testbusiness.industryRehabilitationHyperandrogenismCase-control studyObstetrics and GynecologyOdds ratioGlucose Tolerance Testmedicine.diseasePolycystic ovaryOligomenorrheaPhenotypeEndocrinologyReproductive MedicineCardiovascular DiseasesCase-Control StudiesFemaleInsulin ResistanceMetabolic syndromebusinessPolycystic Ovary Syndrome
researchProduct

The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancy.

2014

During pregnancy, regulatory T cells (Tregs) have a key role in maternal immune tolerance to the semi-allogeneic fetus. Our previous results showed that the naive CD45RA(+)-Treg pool is functionally improved in pregnant women compared with non-pregnant women. Therefore, we examined the thymic output and differentiation of CD45RA(+)CD31(+) recent thymic emigrant (RTE)-Tregs during normal pregnancy and in the presence of preeclampsia. With the onset of pregnancy, the composition of the total CD4(+)CD127(low+/-)FoxP3(+)-Treg pool changed in the way that its percentage of RTE- and CD45RA(-)CD31(+)-memory Tregs decreased strongly, whereas that of the CD45RA(+)CD31(-)-mature naive (MN)-Tregs did …

Adultmedicine.medical_specialtyAdolescentRegulatory T cellImmunologyRecent Thymic Emigrantchemical and pharmacologic phenomenaThymus GlandT-Lymphocytes RegulatoryPreeclampsiaImmune toleranceYoung AdultPre-EclampsiaPregnancyT-Lymphocyte SubsetsInternal medicineImmune ToleranceImmunology and AllergyMedicineAnimalsHumansInterleukin-7 receptorFetusPregnancybusiness.industryFOXP3hemic and immune systemsCell DifferentiationForkhead Transcription FactorsCell BiologyMiddle Agedmedicine.diseasemedicine.anatomical_structureEndocrinologyLeukocyte Common AntigensFemalebusinessImmunologic MemoryImmunology and cell biology
researchProduct

Identifying women with gestational diabetes based on maternal characteristics: an analysis of four Norwegian prospective studies

2021

Abstract Background There is still no worldwide agreement on the best diagnostic thresholds to define gestational diabetes (GDM) or the optimal approach for identifying women with GDM. Should all pregnant women perform an oral glucose tolerance test (OGTT) or can easily available maternal characteristics, such as age, BMI and ethnicity, indicate which women to test? The aim of this study was to assess the prevalence of GDM by three diagnostic criteria and the predictive accuracy of commonly used risk factors. Methods We merged data from four Norwegian cohorts (2002–2013), encompassing 2981 women with complete results from a universally offered OGTT. Prevalences were estimated based on the f…

Adultmedicine.medical_specialtyDiagnostic criteriaendocrine system diseasesReproductive medicine:Medisinske Fag: 700::Klinisk medisinske fag: 750::Gynekologi og obstetrikk: 756 [VDP]NorwegianWorld Health OrganizationLogistic regressionGestational diabetes mellitusBody Mass IndexPredictive Value of TestsRisk FactorsPregnancyEthnicityPrevalencemedicineScreening methodHumansProspective StudiesProspective cohort studyPregnancyDiagnostic Tests RoutineNorwayObstetricsbusiness.industryResearchAge FactorsObstetrics and Gynecologynutritional and metabolic diseasesGynecology and obstetricsGlucose Tolerance Testmedicine.diseasePre pregnancy BMIlanguage.human_languagePeer reviewGestational diabetesDiabetes GestationalVDP::Medisinske Fag: 700::Helsefag: 800ScreeningRG1-991languageFemalebusiness
researchProduct

Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily.

2019

Objective To better characterize the metabolic alterations in various phenotypes of polycystic ovary syndrome (PCOS) in a large homogeneous (Sicilian) Mediterranean population with a low prevalence of obesity. Design Retrospective study. Patients A total of 1215 consecutively evaluated women with PCOS divided into four Rotterdam phenotypes (A, B, C and D) and in 108 matched ovulatory, nonhyperandrogenic women. Measurements BMI, fasting glucose, total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol and an oral glucose tolerance test. Results The overall prevalence of obesity was 31%, metabolic syndrome 6.6%, diabetes 2.1%, altered glucose metabolism 13.1%, and abnormal lipid pro…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismCarbohydrate metabolism03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineHumanseducationSicilyTriglyceridesRetrospective Studieseducation.field_of_studybusiness.industryCholesterolCholesterol HDLCholesterol LDLGlucose Tolerance Testmedicine.diseasePolycystic ovaryPhenotypeObesityEndocrinologychemistry030220 oncology & carcinogenesisFemaleMetabolic syndromebusinessPolycystic Ovary SyndromeClinical endocrinologyREFERENCES
researchProduct

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.

1986

This study examined the effects of the long-acting selective mini somatostatin analogue (SMS) 201-995 in two acromegalic patients who were treated for 3 and 6 months, respectively. During treatment the mean growth hormone levels (25.3 and 20.8 ng/ml vs 5.9 and 10.6 ng/ml) and somatomedin C levels (6.2 and 6.2 IU/ml vs 3.3 and 3.8 IU/ml) decreased and the patients reported an improvement in their symptoms. The main side effect was an increase in stool fat excretion which did exceed the normal range (less than 7 g/day) in one patient. Five acromegalics who received 2 X 50 micrograms SMS 201-995/day for 5 days showed a significant increase of stool fat excretion (1.7 vs 3.5 g/day; p less than …

Adultmedicine.medical_specialtyLong term treatmentSide effectAntineoplastic AgentsOctreotideExcretionInternal medicineDrug DiscoveryAcromegalyMedicineHumansPituitary NeoplasmsGenetics (clinical)Glycated Hemoglobinbusiness.industryAdenoma AcidophilGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseSomatomedinCombined Modality TherapyLong-Term CareSomatostatin AnalogueSomatostatinEndocrinologyGrowth HormoneAcromegalyMolecular MedicineFemaleHemoglobinNeoplasm Recurrence LocalbusinessSomatostatinKlinische Wochenschrift
researchProduct

Health-Promoting Effects of Serial vs. Integrated Combined Strength and Aerobic Training

2016

Combined strength and aerobic training programs are widely used for improving markers of physical fitness and health. We compared the efficiency of a serial and an integrated combined training program on health and overall fitness in middle-aged females. 54 females (46.7±4.5yrs) were assigned to a serial (SCG) or an integrated (ICG) combined training group or to a control group (CG). The SCG and ICG performed a 3-month training combining aerobic dance and calisthenics. The 2 training programs differ in the sequence of aerobic and strength exercises. SCG performed the strength exercises prior to aerobic; in ICG, the aerobic and strength exercises were altered in a predetermined order. Body c…

Adultmedicine.medical_specialtyPhysical fitnessPhysical Therapy Sports Therapy and RehabilitationHealth Promotion02 engineering and technology03 medical and health sciencesOxygen Consumption0302 clinical medicinePhysical medicine and rehabilitationHeart RateHeart rate0202 electrical engineering electronic engineering information engineeringmedicineHumansAerobic exerciseOrthopedics and Sports MedicineRespiratory functionMuscle Strength030212 general & internal medicineDancingAerobic capacityBalance (ability)Exercise Tolerancebusiness.industryResistance Training020206 networking & telecommunicationsCardiorespiratory fitnessMiddle AgedCardiorespiratory FitnessPhysical FitnessBody CompositionPhysical EndurancePhysical therapyFemaleCalisthenicsbusinessInternational Journal of Sports Medicine
researchProduct

Immune Tolerance Induction in Hemophilia A: A Review

2003

In this article, a comparative analysis of the data stemming from the studies conducted in the field of immune tolerance treatment (ITT) of hemophilia A was attempted. Comparisons are difficult because previous studies differ in many respects, including the dosage of factor (F) VIII, the number of FVIII administrations per day, the association with immunosuppressive drugs (prednisone, cyclophosphamide), and, most importantly, the definition of success in terms of the reacquisition of tolerance. However, a number of variables consistently influenced outcome: the inhibitor titer, either the maximum one or the one assayed before immune tolerance (IT) start and age. As to the FVIII dose, result…

Adultmedicine.medical_specialtyTime FactorsAdolescentDoseCyclophosphamideHemophilia AImmune toleranceVon Willebrand factorPrednisoneInternal medicineImmune ToleranceCoagulopathyHumansMedicineChildFactor VIIIbiologybusiness.industryInfantHematologymedicine.diseaseRecombinant ProteinsKineticsTreatment OutcomeChild PreschoolImmunologyChemoprophylaxisbiology.proteinCardiology and Cardiovascular MedicinebusinessBypassing agentmedicine.drugSeminars in Thrombosis and Hemostasis
researchProduct

LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALY

1984

In 6 of 7 acromegalic patients a single subcutaneous injection of 50 micrograms of a new octapeptide somatostatin analogue (SMS 201-995) reduced serum growth hormone (GH) from 30 +/- 12 ng/ml to 1.4 +/- 0.4 (mean +/- SEM). Serum GH remained below basal concentration for 9 h. In the remaining patient who had very high basal preprandial serum GH, SMS 201-995 produced a reduction in serum GH of only 20%. Plasma glucose concentrations were increased to the upper limits of the normal range when a high-carbohydrate meal was consumed 2 h after injection. In non-diabetic patients plasma glucose did not exceed 129 mg/dl. The 40% decrease in plasma glucagon, which lasted for 7 h after SMS 201-995 inj…

Adultmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPeptide hormoneOctreotideEatingSubcutaneous injectionInternal medicineAcromegalymedicineHumansInsulinAgedChemotherapyMealChemistryGeneral MedicineGlucose Tolerance TestMiddle AgedGlucagonmedicine.diseaseGrowth hormone secretionEndocrinologySomatostatinBasal (medicine)Growth HormoneAcromegalySomatostatinThe Lancet
researchProduct

Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of …

2013

Study question Is it possible to distinguish metabolically healthy polycystic ovary syndrome (MH-PCOS) from metabolically unhealthy PCOS (MU-PCOS) by simple diagnostic tools such as body mass index (BMI), waist/hip ratio (WHR), at-risk category suggested by Androgen Excess Society (AES) and visceral adiposity index (VAI)? Summary answer VAI could be an easy and useful tool in clinical practice and in population studies for assessment of MU-PCOS. What is known already VAI is a good indicator of insulin sensitivity and cardiometabolic risk in oligo-ovulatory women with PCOS. Study design, size, duration We conducted a cross-sectional study of 232 women with PCOS in a university hospital setti…

Adultmedicine.medical_specialtyWaistAdolescentPopulationSettore MED/13 - EndocrinologiaDiagnosis DifferentialInsulin resistanceRisk FactorsInternal medicinemedicinePCOSHumanseducationAdiposityeducation.field_of_studybusiness.industryRehabilitationnutritional and metabolic diseasesObstetrics and GynecologyOdds ratioGlucose Tolerance Testmedicine.diseasePolycystic ovaryConfidence intervalCross-Sectional StudiesPhenotypeReproductive MedicineFemaleMetabolic syndromeInsulin ResistancebusinessEnergy MetabolismBody mass indexPolycystic Ovary SyndromeHuman reproduction (Oxford, England)
researchProduct